Evidence map›Paper›PMID 10503237›Full record

ArticleMolecular biotechnology1999

Reconstitution of fibroblast growth factor receptor interactions in the yeast two hybrid system.

R Aloni-Grinstein, A Seddon, A Yayon

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

R Aloni-GrinsteinDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
A Seddon
A Yayon
Weizmann Institute of Science · ILPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factors (FGF) activate their receptors through the formation of trimolecular complexes, composed of a ligand, a receptor, and a heparan sulfate oligosaccharide, all of which are members of particularly large families capable of multiple interactions in a combinatorial fashion. Understanding this large network of interactions not only presents a great challenge, but is practically beyond the capacity of most classical techniques routinely used to study ligand receptor interactions. We have used the yeast two hybrid system to study protein-protein interactions in the FGF family. Both ligand and receptor ectodomains are properly folded and functional in the yeast. Basic FGF (bFGF) expressed in the yeast dimerizes spontaneously. This self-assembly occurs at low affinity, which can be greatly enhanced by the introduction of heparin, supporting a defined role for heparin in bFGF dimerization. Screening a rat embryo cDNA library with bFGF in the yeast two hybrid system identified a short variant of FGF receptor 1, found most frequently in embryonal and tumor cells and which possesses affinity toward bFGF that is significantly greater than that of the more abundant, full-length receptor. We find the yeast two hybrid system, a most suitable alternative method for the analysis of growth factor-receptor interactions as well as for screening for novel interacting proteins and modulators of FGF and its receptors.

Indexed as

Saccharomyces cerevisiae ProteinsTwo-Hybrid System TechniquesAnimalsCloning, MolecularDimerizationDNA-Binding ProteinsDNA, ComplementaryFibroblast Growth Factor 2Fungal ProteinsHeparinRatsReceptors, Fibroblast Growth FactorRecombinant Fusion ProteinsSaccharomyces cerevisiaeTranscription FactorsDNA-Binding ProteinsDNA, ComplementaryFibroblast Growth Factor 2Fungal ProteinsGAL4 protein, S cerevisiaeHeparinReceptors, Fibroblast Growth FactorRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID10503237
OpenAlexW2153010105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.